ArticleFrontiers in endocrinology2025
Integrative proteomics and metabolomics analysis of the mechanism of pancreatic β-cell dysfunction in aged mice.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: The prevalence of type 2 diabetes mellitus has increased worldwide and is higher among older individuals. Exploring the mechanisms underlying pancreatic β-cell dysfunction may help elucidate the pathogenesis of age-related diabetes. Methods: Islet function-related parameters were measured in four young and four aged mice. Endogenous proteins and metabolites in the pancreas were detected using liquid chromatography-tandem mass spectrometry (LC-MS/MS)-based proteomics and metabolomics, and integrated data analysis was performed. Results: Compared with young mice, aged mice presented higher fasting blood glucose levels and insulin resistance index (according to the homeostatic model assessment for insulin resistance, HOMA-IR), whereas that from the homeostasis model assessment of β-cell function (HOMA-β) significantly decreased. A total of 3,795 proteins were quantified, 57 of which were upregulated and 50 were downregulated in aged mice. Moreover, 46 metabolites were significantly upregulated and 19 were downregulated in aged mice. Integrated proteomic and metabolomic analyses revealed six significant pathways implicated in these changes, including arginine biosynthesis and the pentose phosphate pathway. By integrating comprehensive multi-omics data, the arginine biosynthesis-related metabolites aspartate and glutamine were found to be associated with the aging phenotype and islet function. Conclusion: These findings suggest that concurrent endogenous protein and metabolite disturbances occur in the pancreas of aged mice, and metabolite aspartate and glutamine may serve as potential biomarkers and therapeutic targets for aging-related pancreatic dysfunction.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.